Response to the letter from Horowitz et al. to the Editor relating to the publication ‘Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes’ by Dahl et al.

Diabetes, Obesity and MetabolismVolume 23, Issue 10 p. 2414-2416 LETTER TO THE EDITOR Response to the letter from Horowitz et al. to the Editor relating to the publication ‘Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes’ by Dahl et al. Kirsten Dahl DVM, Corresponding Author Kirsten Dahl DVM kdhl@novonordisk.com orcid.org/0000-0001-5063-1554 Novo Nordisk A/S,...